--- title: "PureTech Health (PRTC) news: delisting" url: "https://aibio.space/companies/puretech-health/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "PRTC delisting news: PureTech Health PLC files Form 25 to delist its ADSs from Nasdaq. PureTech Health PLC (LSE: PRTC), United States." --- PRTC PureTech Health PLC LSE · United States # PureTech Health (PRTC) news PRTC delisting news Listings · 2026-05-11 ## [PureTech Health PLC files Form 25 to delist its ADSs from Nasdaq](https://aibio.space/news/puretech-health-plc-files-form-25-delist-adss-nasdaq/) The filing, dated May 11, 2026, relies on the SEC rule for a voluntary withdrawal by the issuer. It covers American Depositary Shares, each representing 10 ordinary shares. ## Latest PureTech Health news 1. 2026-04-29 Listings [PureTech to delist ADSs from Nasdaq and keep its primary London listing](https://aibio.space/news/puretech-delist-adss-nasdaq-keep-primary-london-listing/) PureTech will delist its American Depositary Shares from Nasdaq and keep its London listing. The Form 25 is expected around May 11, 2026, with the last Nasdaq trading day around May 20, and the company plans to deregister with the SEC afterward. ## PureTech Health at a glance - **Ticker**: PRTC - **Listing**: LSE - **Country**: United States - **Cash, Dec 31, 2024**: $280.6 million ### Related companies - [GridAI Technologies](https://aibio.space/companies/gridai-technologies/) NASDAQ: GRDX - [Axsome Therapeutics](https://aibio.space/companies/axsome-therapeutics/) NASDAQ: AXSM - [United Therapeutics](https://aibio.space/companies/united-therapeutics/) NASDAQ: UTHR - [Stoke Therapeutics](https://aibio.space/companies/stoke-therapeutics/) NASDAQ: STOK - [ProKidney](https://aibio.space/companies/prokidney/) NASDAQ: PROK - [UroGen Pharma](https://aibio.space/companies/urogen-pharma/) NASDAQ: URGN - [MAIA Biotechnology](https://aibio.space/companies/maia-biotechnology/) AMEX: MAIA - [Dyne Therapeutics](https://aibio.space/companies/dyne-therapeutics/) NASDAQ: DYN ### Also on LSE - [Ondine Biomedical](https://aibio.space/companies/ondine-biomedical/) OBI - [HemoGenyx Pharmaceuticals Plc](https://aibio.space/companies/hemogenyx-pharmaceuticals/) HEMO - [Futura Medical](https://aibio.space/companies/futura-medical/) FUM - [Venture Life Group Plc](https://aibio.space/companies/venture-life/) VLG - [Avacta Group](https://aibio.space/companies/avacta/) AVCT - [Bioventix Plc](https://aibio.space/companies/bioventix/) BVXP ## What PureTech Health does PureTech Health PLC says its pipeline builds on validated biology of known therapeutics, with unique inventive steps intended to improve clinical pharmacology, and that its technology and drug discovery and development expertise give it a competitive advantage. It also advances products through what it calls Founded Entities. Two internal product candidates are named in the competition section. LYT-100 is aimed at idiopathic pulmonary fibrosis, where the text lists three approved drugs: pirfenidone (Esbriet), nintedanib (Ofev) and nerandomilast (Jascayd). LYT-200 targets galectin-9. The text says it seeks to be the first non-targeted therapy approved in relapsed or refractory acute myeloid leukemia, and that it could also compete as an immuno-oncology treatment. The only other galectin-9 candidate the text mentions is FibroGen's FG-3165, which received IND clearance in June 2024 for solid tumors. The company's business overview and revenue information are incorporated by reference from its Annual Report and Accounts 2025. | Product or program | What it is | Stage | |---|---|---| | LYT-100 | Internal candidate in idiopathic pulmonary fibrosis (IPF) | | | LYT-200 | Galectin-9 targeting candidate for relapsed or refractory AML and immuno-oncology | | Summarised from the company's [20-F filed Apr 29, 2026](https://www.sec.gov/Archives/edgar/data/1782999/000162828026028200/ptv-20251231.htm). ## PureTech Health annual financials | Line | FY2024 | FY2023 | |---|---|---| | Revenue | [$4.8 million](https://www.sec.gov/Archives/edgar/data/1782999/000178299925000005/) | [$3.3 million](https://www.sec.gov/Archives/edgar/data/1782999/000178299925000005/) | | Research and development | [$69.5 million](https://www.sec.gov/Archives/edgar/data/1782999/000178299925000005/) | [$96.2 million](https://www.sec.gov/Archives/edgar/data/1782999/000178299925000005/) | | Net income (loss) | [$27.8 million](https://www.sec.gov/Archives/edgar/data/1782999/000178299925000005/) | [-$66.6 million](https://www.sec.gov/Archives/edgar/data/1782999/000178299925000005/) | | Cash from operations | [-$134.4 million](https://www.sec.gov/Archives/edgar/data/1782999/000178299925000005/) | [-$105.9 million](https://www.sec.gov/Archives/edgar/data/1782999/000178299925000005/) | | Cash and equivalents | [$280.6 million](https://www.sec.gov/Archives/edgar/data/1782999/000178299925000005/) | [$191.1 million](https://www.sec.gov/Archives/edgar/data/1782999/000178299925000005/) | Latest balance sheet, Dec 31, 2024 (20-F): cash and equivalents $280.6 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about PureTech Health Was PureTech Health delisted? Our latest story on this, dated May 11, 2026: "PureTech Health PLC files Form 25 to delist its ADSs from Nasdaq". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/puretech-health-plc-files-form-25-delist-adss-nasdaq/). What is the ticker symbol of PureTech Health? PureTech Health PLC trades under the ticker PRTC on LSE. Where is PureTech Health listed? PureTech Health PLC is listed on LSE. Our directory also records these other listings: DUS:0VQ; FWB:0VQ; OTC:PRTCY; OTC:PTCHF; SWB:0VQ. What is the SEC CIK of PureTech Health? The SEC Central Index Key (CIK) for PureTech Health PLC is 1782999. Its filings are on SEC EDGAR. How many shares does PureTech Health have outstanding? 241,684,038 shares as of 2025-12-31, per the cover page of its 20-F filed 2026-04-29. Which country or territory is PureTech Health listed under? Our directory records PureTech Health PLC under United States. What does PureTech Health do? Our directory classifies PureTech Health PLC as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of PureTech Health? The ISIN recorded for PureTech Health PLC is GB00BY2Z0H74. Does aibio.space cover PureTech Health? aibio.space lists PureTech Health PLC among 2,820 public biotech companies and publishes its news here as stories appear. Where is PureTech Health incorporated? SEC records list its state or country of incorporation as X0. What does PureTech Health develop? PureTech Health PLC says its pipeline builds on validated biology of known therapeutics, with unique inventive steps intended to improve clinical pharmacology, and that its technology and drug discovery and development expertise give it a competitive advantage. It also advances products through what it calls Founded Entities. What is LYT-100 from PureTech Health? LYT-100: Internal candidate in idiopathic pulmonary fibrosis (IPF) What is LYT-200 from PureTech Health? LYT-200: Galectin-9 targeting candidate for relapsed or refractory AML and immuno-oncology What was PureTech Health's revenue last year? $4.8 million for the fiscal year ended Dec 31, 2024, as reported to the SEC. Is PureTech Health profitable? PureTech Health PLC reported net income of $27.8 million for the fiscal year ended Dec 31, 2024, and used $134.4 million of cash in operations, per its annual report to the SEC. ## Investor discussion: PureTech Health Members talk about PureTech Health (PRTC). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at PureTech Health, newest first. Each line links the filing it comes from. 1. 2026-05-11 Listings Filed to remove its shares from exchange listing. SEC Form 25. [Source](https://www.sec.gov/Archives/edgar/data/1782999/000119312526216746/d54446d25.htm) 2. 2026-04-29 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1782999/000119312526188793/d37980dex991.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open LSE:PRTC on TradingView](https://www.tradingview.com/symbols/LSE-PRTC/). ## SEC filings and registration - **SEC name**: PureTech Health plc - **CIK**: 1782999 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: PTCHF (OTC), PRTCY (OTC) - **State or country of incorporation**: X0 - **Fiscal year ends**: December 31 - **Filer category**: Accelerated filer - **Business address**: 6 TIDE STREET, BOSTON, MA, 02210 - **Phone**: 617-482-2333 - **Shares outstanding**: 241,684,038 as of 2025-12-31 (20-F filed 2026-04-29) ### Recent filings (8-K and 6-K are the company's own announcements) - [6-K](https://www.sec.gov/Archives/edgar/data/1782999/000119312526199177/d22215d6k.htm) filed 2026-05-01 - [20-F](https://www.sec.gov/Archives/edgar/data/1782999/000162828026028200/ptv-20251231.htm) filed 2026-04-29 - [6-K](https://www.sec.gov/Archives/edgar/data/1782999/000119312526188811/d38199d6k.htm) filed 2026-04-29 - [6-K](https://www.sec.gov/Archives/edgar/data/1782999/000119312526188793/d37980d6k.htm) filed 2026-04-29 - [6-K](https://www.sec.gov/Archives/edgar/data/1782999/000119312525323679/d76650d6k.htm) filed 2025-12-18 - [6-K](https://www.sec.gov/Archives/edgar/data/1782999/000119312525314304/d933871d6k.htm) filed 2025-12-10 - [6-K](https://www.sec.gov/Archives/edgar/data/1782999/000162828025041238/a6-kformhy2025hyonly.htm) filed 2025-08-28 - [6-K](https://www.sec.gov/Archives/edgar/data/1782999/000119312525159538/d863451d6k.htm) filed 2025-07-16 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001782999), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details PureTech Health PLC is a public biotech or pharmaceutical company listed on LSE under the ticker PRTC, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: PureTech Health PLC - **Ticker**: PRTC - **Listing**: LSE - **Country or territory**: United States - **Business scope**: Biotechnology - **ISIN**: GB00BY2Z0H74 - **Other listed symbols**: DUS:0VQ; FWB:0VQ; OTC:PRTCY; OTC:PTCHF; SWB:0VQ - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/LSE-PRTC/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/puretech-health/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "PureTech Health (PRTC) news: delisting", 2026-10-31, https://aibio.space/companies/puretech-health/